| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000nam a22000007i 4500 |
| 001 |
in00005690688 |
| 005 |
20260215001254.0 |
| 006 |
m o d |
| 007 |
cr cnu---|nuuu |
| 008 |
250612t20252025nju o 000 0 eng d |
| 035 |
|
|
|a wil6005422
|
| 035 |
|
|
|a (NhCcYBP)wil6005422
|
| 040 |
|
|
|a NhCcYBP
|b eng
|e rda
|c NhCcYBP
|
| 020 |
|
|
|a 9781394287345
|q electronic book
|
| 020 |
|
|
|a 1394287348
|q electronic book
|
| 020 |
|
|
|a 9781394287338
|q electronic book
|
| 020 |
|
|
|a 139428733X
|q electronic book
|
| 020 |
|
|
|a 1394287321
|
| 020 |
|
|
|a 9781394287321
|q (electronic bk.)
|
| 020 |
|
|
|z 9781394287314
|q hardcover
|
| 020 |
|
|
|z 1394287313
|q hardcover
|
| 024 |
7 |
|
|a 10.1002/9781394287345
|2 doi
|
| 024 |
8 |
|
|a CIPO000255221
|
| 050 |
|
4 |
|a R857.N34
|b B56 2025
|
| 082 |
0 |
4 |
|a 610.28
|2 23/eng/20250717
|
| 245 |
0 |
0 |
|a Bioactive-based nanotherapeutics /
|c edited by Rakesh K. Sindhu, Sumitra Singh, Evren Algin Yapar.
|
| 264 |
|
1 |
|a Hoboken, NJ :
|b John Wiley & Sons, Inc. ;
|a Beverly, MA :
|b Scrivener Publishing LLC,
|c 2025.
|
| 264 |
|
4 |
|c ©2025
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/c
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/cr
|
| 532 |
1 |
|
|3 Wiley
|a "We measure accessibility according to the standards set by the Web Content Accessibility Guidelines (WCAG) 2.2 A/AA, Revised Section 508 of the US Rehabilitation Act, and EN 301 549." Source: https://onlinelibrary.wiley.com/accessibility. Last accessed April 22, 2025
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on July 17, 2025).
|
| 505 |
0 |
|
|a Cover -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- Chapter 1 Basics of Nano-Bioactive Compounds and Their Therapeutic Potential -- 1.1 Introduction -- 1.2 Therapeutic Potential of Bioactive Compounds -- 1.2.1 Alkaloids -- 1.2.1.1 Medicinal Use of Alkaloids as Bioactive Molecule -- 1.2.2 Antibiotics -- 1.2.2.1 Medicinal Use of Antibiotics as Bioactive Molecule -- 1.2.3 Mycotoxins -- 1.2.3.1 Medicinal Use of Mycotoxins as Bioactive Molecule -- 1.2.4 Growth Factors -- 1.2.4.1 Medicinal Use of Growth Factors as Bioactive Compounds -- 1.2.5 Phenolics
|
| 505 |
8 |
|
|a 1.2.5.1 Medicinal Use of Phenolics as Bioactive Compounds -- 1.3 Extraction Techniques for Obtaining Bioactive Compound -- 1.4 Novel Delivery Approach for Bioactive Compounds -- 1.5 Electrospinning -- 1.6 Micro- and Nanoencapsulation of Bioactive Compounds -- 1.7 Polymeric Nanoparticles (NPs) -- 1.8 Solid Lipid Nanoparticles -- 1.9 Nanoemulsions -- 1.10 Nanocrystals -- 1.11 Phytosomes -- 1.12 Therapeutic Potential of Nano-Bioactive Compounds -- 1.13 Conclusion -- References -- Chapter 2 Recent Techniques for Isolation of Bioactive Components from Plants -- 2.1 Introduction
|
| 505 |
8 |
|
|a 2.2 Extraction Methods -- 2.2.1 Ultrasound-Assisted Extraction (UAE) -- 2.2.2 Supercritical Fluid Extraction (SFE) -- 2.2.3 Microwave-Assisted Extraction (MAE) -- 2.2.4 Molecular Imprinting Technology (MIT) -- 2.3 Recent Chromatographic Methods -- 2.3.1 Liquid Chromatography (LC) and Gas Chromatography (GC) -- 2.3.2 High-Performance Liquid Chromatography (HPLC) and Tandem Mass Spectrometry (MS/MS) -- 2.3.3 Supercritical Fluid Chromatography (SFC) -- 2.3.4 Two-Dimensional Chromatographic Approaches -- 2.4 Applications of Two-Dimensional Chromatographic Approaches -- 2.5 Hyphenated Techniques
|
| 505 |
8 |
|
|a 2.6 Conclusion -- References -- Chapter 3 Bioactive-Based Nanocarriers for Inflammatory Diseases -- 3.1 Inflammation and Diseases -- 3.2 Nanocarriers as Drug Delivery System -- 3.3 Nanocarriers and Inflammation -- 3.4 Inflammation in Central Nervous System -- 3.4.1 Etiology of CNS Inflammation -- 3.4.2 The Blood-Brain Barrier (BBB) -- 3.4.3 Immune Response -- 3.4.4 Clinical Manifestations -- 3.4.5 Diagnosis and Therapeutic Approaches -- 3.4.6 Chronic Inflammation -- 3.5 Ophthalmological Inflammation -- 3.5.1 Causes of Ophthalmological Inflammation
|
| 505 |
8 |
|
|a 3.5.2 Symptoms of Ophthalmological Inflammation -- 3.5.3 Diagnosis and Treatment -- 3.6 Cardiovascular Inflammation -- 3.6.1 Significance of Inflammation -- 3.6.2 Factors Contributing to Inflammation -- 3.6.3 Role of Cytokines and Chemokines -- 3.6.4 Distinguishing Acute and Chronic Inflammation -- 3.6.5 Consequences of Chronic Inflammation -- 3.6.6 Treatment and Prevention -- 3.6.7 Use of Biomarkers -- 3.6.8 Ongoing Research -- 3.6.9 Nanocarriers Used in the Treatment of Cardiovascular Inflammation -- 3.7 Respiratory Inflammation -- 3.7.1 Origins of Respiratory Inflammation
|
| 520 |
|
|
|a The book provides essential insights into the revolutionary potential of nanotechnology in medicine, exploring innovative approaches that harness natural materials for targeted and effective disease management. Nanotechnology has emerged as an innovative field with the potential to transform various sectors, including medicine and allied health sciences. Bioactive nanotherapeutics, a specific area within nanotherapeutics, utilizes natural materials or biomimetic designs to offer distinct advantages such as targeted drug delivery, biocompatibility, and improved therapeutic efficacy. These bioactive-based nanotherapeutics are used in the treatment and management of various diseases. Bioactive-Based Nanotherapeutics explores this rapidly growing field of therapeutics. It presents a broad overview of the fundamentals of bioactive nanomaterials, their design strategies, and their therapeutic applications. Leading experts from different disciplines have contributed chapters that explore a diverse range of topics, including the basics of bioactive nanotherapeutics, isolation methods of different bioactive compounds, and formulation developments. This volume addresses the importance of nanotechnology for the treatment and management of different diseases, including nasal, gastrointestinal, rectal, and transdermal diseases. Readers will find the book: Provides scientific research and evidence that supports the effectiveness of bioactive-based nanocarriers in treating diseases; Explores actionable steps and real-life scenarios to illustrate the practical benefits; Provides a comprehensive guide that explains the holistic approach, explaining health-related applications of bioactive-based nanoformulations. Audience Pharmacists, biologists, chemists, doctors, academics, and industry professionals interested in holistic and bioactive-based methods for disease treatment.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
0 |
|a Electronic books.
|
| 650 |
|
2 |
|a Nanomedicine
|
| 655 |
|
0 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|z 1394287313
|z 9781394287314
|
| 776 |
0 |
8 |
|i Print version:
|z 9781394287314
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://onlinelibrary.wiley.com/book/10.1002/9781394287345
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Wiley EBA record
|
| 975 |
|
|
|p Wiley UBCM Full Collection
|
| 976 |
|
|
|a 6005422
|
| 999 |
f |
f |
|i 79af0177-a646-4656-8b91-e9ee73bbe622
|s a8ec3873-5a35-4ef1-ba0d-7040f3f56e82
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s evans_pda
|d Available Online
|t 0
|e R857.N34 B56 2025
|h Library of Congress classification
|
| 998 |
f |
f |
|a R857.N34 B56 2025
|t 0
|l Available Online
|